Healthcare Triangle, Inc. (HCTI): Nasdaq/NYSE listing notice — Healthcare Triangle delisting notice from Nasdaq; hearing requested

Healthcare Triangle, Inc.

Received Nasdaq delisting notice on May 31, 2023 for failing to meet minimum bid price rule by May 30 deadline.
Trading suspension set for June 9, 2023 unless appeal; company requested hearing on June 5, staying delisting.
Hearing scheduled for July 20, 2023; company also submitted expedited review questionnaire to Nasdaq.
Effected 1-for-10 reverse stock split on May 26, 2023; stock closed above $2.60 for 6 trading days since.
No assurance that compliance plan will be accepted or that company can regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Healthcare Triangle, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 31, 2023, Healthcare Triangle, Inc. (the “Company”) received a notice (the “Delisting Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that Nasdaq has determined the Company did not regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by May 30, 2023, the deadline to regain compliance with the Rule pursuant to the notice the Company received from Nasdaq on December 1, 2022 (the “Extension Notice”), and therefore the

View on SEC.gov

Browse all listing & compliance notices →

Healthcare Triangle, Inc. filing history →

Source: SEC EDGAR

accession 0001607062-23-000322

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.